AI-based method predicts risk of atrial fibrillation – Harvard Gazette

Sign up for daily emails to get the latest Harvard news.
Harvard University
Pledges and coalitions, mitigation and adaptation, taking to the streets and fringe music fests as conference winds down
Education scholars debunk myth that young people today are lazier, more immature than prior generations
Artificial intelligence-based method predicts risk of atrial fibrillation, helping clinicians protect patients’ heart health
Less sodium and more potassium could be key in lowering risk of cardiovascular disease
© 2021 The President and Fellows of Harvard College
Using artificial intelligence, risk of atrial fibrillation can be predicted up to five years out, based on results from electrocardiograms.

An artificial intelligence-based method for identifying patients who are at risk for atrial fibrillation has been developed by a team led by researchers at Harvard-affiliated Massachusetts General Hospital and the Broad Institute of MIT and Harvard
Atrial fibrillation — an irregular and often rapid heart rate — is a common condition that often leads to the formation of clots in the heart that can travel to the brain to cause a stroke. The study was published in Circulation.
The investigators developed the artificial intelligence-based method to predict the risk of atrial fibrillation within the next five years based on results from electrocardiograms (noninvasive tests that record the electrical signals of the heart) in 45,770 patients receiving primary care at MGH.
Next, the scientists applied their method to three large data sets from studies including a total of 83,162 individuals. The AI-based method predicted atrial fibrillation risk on its own and was synergistic when combined with known clinical risk factors for predicting atrial fibrillation. The method was also highly predictive in subsets of individuals such as those with prior heart failure or stroke.
“We see a role for electrocardiogram-based artificial intelligence algorithms to assist with the identification of individuals at greatest risk for atrial fibrillation,” says senior author Steven A. Lubitz, a cardiac electrophysiologist at MGH, an associate member at the Broad Institute, and associate professor of medicine at Harvard Medical School.
The algorithm could serve as a form of pre-screening tool for patients who may currently be experiencing undetected atrial fibrillation, prompting clinicians to search for atrial fibrillation using longer-term cardiac rhythm monitors, which could in turn lead to stroke prevention measures, explains Lubitz.
The study’s findings also demonstrate the potential power of AI — which in this case involve a specific type called machine learning — to advance medicine. “With the explosion of data science technologies and the vast amounts of clinical data now available, machine learning is poised to help clinicians and researchers make great strides in enhancing cardiology care,” says co-author Anthony Philippakis, chief data officer at the Broad and co-director of the institute’s Eric and Wendy Schmidt Center. “As a data scientist and former cardiologist, I’m excited to see how machine learning–based methods can work with the tests and clinical approaches we use every day to help us improve risk prediction and take care of patients with atrial fibrillation.”
Adds co–lead author Shaan Khurshid, an electrophysiology clinical and research fellow at MGH: “The application of such algorithms could prompt clinicians to modify important risk factors for atrial fibrillation that may reduce the risk of developing the disease altogether.”
Co–lead author is Shaan Khurshid, an electrophysiology clinical and research fellow at MGH; co-authors include Samuel Friedman, Christopher Reeder, Paolo Di Achille, Nathaniel Diamant, Pulkit Singh, Lia X. Harrington, Xin Wang, Mostafa A. Al-Alusi, Gopal Sarma, Andrea S. Foulkes, Patrick T. Ellinor, Christopher D. Anderson, Jennifer E. Ho, and Puneet Batra.
This work was supported by the National Institutes of Health, the American Heart Association, the Doris Duke Foundation, and the Leducq Foundation.
Med School specialists say they may cut hospitalizations, deaths and offer big boost to nations struggling with low vaccination rates
Pledges and coalitions, mitigation and adaptation, taking to the streets and fringe music fests as conference winds down
100 years after discovery of insulin, replacement therapy represents ‘a new kind of medicine,’ says Stem Cell Institute co-director Douglas Melton, whose children inspired his research
For every 1,000 mg increase in sodium consumption, risk of cardiovascular disease went up by 18 percent, while a 1,000 mg increase in potassium offered an 18 percent risk reduction, according to a large-scale study.
iStock by Getty Images

Connect with Chris Hood, a digital strategist that can help you with AI.

Leave a Reply

Your email address will not be published. Required fields are marked *

© 2021 AI Caosuo - Proudly powered by theme Octo